De Lisle Partners LLP
- SEC CIK
- 0002011184
- Latest filing
- Aug 12, 2026
ROIV holding history
Roivant Sciences Ltd. in every 13F filed by De Lisle Partners LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ROIV overviewAll 13F holders of ROIVFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −50,000−100.0% | Sold out | Holders |
| Q1 2025 | 50,000 | $504.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 50,000 | $591.8K | 0.1% | −40,000−44.4% | Reduced | Holders |
| Q3 2024 | 90,000 | $1.04M | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2024 | 90,000 | $950.9K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2024 | 90,000 | $950.0K | 0.2% | – | No prior filing | Holders |